268600 — Cellivery Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Cellivery Therapeutics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	27,383	53,814	85,069	14,628	1,459
Net Total Accounts Receivable
Net Total Receivables	553	301	5,538	6,811	3,242
Total Inventory
Total Other Current Assets
Total Current Assets	28,364	54,658	98,385	29,558	7,847
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,587	2,705	24,130	39,064	19,487
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	30,858	60,516	129,841	84,705	30,164
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,084	1,261	26,147	55,123	54,625
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	3,575	22,123	54,834	74,019	54,633
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Total Equity	27,283	38,393	75,007	10,686	-24,469
Total Liabilities & Shareholders' Equity	30,858	60,516	129,841	84,705	30,164
Total Common Shares Outstanding
Total Preferred Shares Outstanding